From
To
TUESDAY, May 27, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for the treatment of plaque psoriasis of the scalp and body in adult and pediatric patients 12 years of age and older.
misbehavior, conflict and family concept - mother entering room and sad daughter sitting on bed at home
National Institutes of Health (NIH) website
Too Much Screen Time Linked to Adolescent Brain Changes and Increased Depression and Anxiety in New Study